Application

16837905 · Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia

Filed 2020-04-01 · Granted · Patent 11911446 (2024-02-27) The official file ↗The patent and its PDF ↗ · Art unit 1646 · Examiner Xiaozhen Xie Typical · CPC A61K 9/19 · BioMarin Pharmaceutical Inc. · Marshall, Gerstein & Borun LLP (Biomarin)

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

7.1 mo

to disposition 46.9 mo

Statutes raised

102 103 112 DP

4 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.